Macular Degeneration: How Early Screening Saves Sight
21/10/2025
 
                31/10/2025
Corneal Cross-Linking: Strengthening the Eye Against Keratoconus
Clear, stable vision depends on a healthy cornea, the transparent front layer of the eye that focuses light. In some people, however, the cornea gradually becomes thin and cone-shaped, causing blurred or distorted vision. This progressive condition is called keratoconus, and without treatment it can severely impact daily life.
At Barraquer, specialists combine early diagnosis with advanced therapeutic technology such as corneal cross-linking (CXL), a minimally invasive procedure designed to halt the progression of keratoconus and preserve vision.
Keratoconus occurs when the collagen fibers in the cornea weaken and lose their structural stability. As the cornea thins, it bulges forward into a cone shape, leading to irregular astigmatism and progressive nearsightedness.
Common signs include:
Blurred or fluctuating vision.
Increased light sensitivity or glare.
Frequent changes in glasses or contact-lens prescriptions.
The condition often begins in the teenage years or early adulthood and may worsen over time if untreated.
Once keratoconus advances, the cornea can become too thin or irregular for contact lenses or safe refractive surgery. In severe cases, a corneal transplant may be required. That’s why early detection through specialized diagnostic imaging is key.
At Barraquer, screening includes:
Corneal topography and tomography: 3D mapping to detect subtle shape changes.
Pachymetry: precise measurement of corneal thickness.
Wavefront analysis: evaluation of optical distortions caused by early irregularities.
Detecting keratoconus in its early stages allows timely intervention with cross-linking before irreversible damage occurs.
Corneal Cross-Linking (CXL) is the only proven treatment that strengthens the cornea by increasing collagen bonds effectively stabilizing the disease rather than masking its symptoms.
How it works:
The outer corneal layer (epithelium) is treated with riboflavin (vitamin B2) drops.
Controlled ultraviolet-A (UVA) light is applied for several minutes.
The combination triggers a natural reaction that creates new collagen “cross-links,” reinforcing the corneal structure.
The goal is not to improve vision immediately, but to stop further thinning and distortion, maintaining the patient’s existing vision and preventing future deterioration.
Barraquer performs corneal cross-linking using state-of-the-art UVA delivery systems that precisely regulate energy, temperature, and exposure time. Every step is guided by detailed pre-operative imaging to ensure maximum safety and accuracy.
Our technological advantages include:
Accelerated and pulsed CXL protocols: shorter treatment time with comparable effectiveness.
Topography-guided CXL: customized energy patterns based on each patient’s corneal map.
Integrated pachymetry monitoring: ensures treatment depth remains within safe limits.
Post-treatment imaging follow-up: OCT and corneal topography used to confirm stabilization over time.
These innovations allow Barraquer’s surgeons to personalize each case and minimize discomfort while maintaining excellent long-term outcomes.
Most patients experience mild irritation or light sensitivity for one to two days after the procedure. The epithelium regenerates naturally, and vision stabilizes gradually over several weeks. Follow-up visits at Barraquer include detailed imaging to verify that the cornea is strengthening and the condition remains stable. Patients can usually resume normal daily activities within a few days, though contact lenses or refractive surgery may be discussed later once the cornea has stabilized.
Corneal cross-linking is ideal for:
Individuals diagnosed with early or progressive keratoconus.
Patients with post-LASIK ectasia (corneal weakening after refractive surgery).
Teenagers or young adults whose keratoconus is still advancing.
It is not typically used to reverse advanced scarring, where a corneal transplant may be more appropriate another area where Barraquer's surgical expertise excels.
Keratoconus management at Barraquer goes beyond treatment. It involves comprehensive patient education, precise diagnoses, and continuous monitoring to ensure lasting stability. By combining clinical experience with leading-edge technology, Barraquer offers patients one of the safest and most effective defenses against vision loss due to keratoconus.
Corneal cross-linking represents a shift from reactive to preventive eye care from correcting vision after it deteriorates to protecting it before damage occurs. At Barraquer, every patient receives individualized assessment and world-class care, ensuring that the strength of their cornea and their sight lasts a lifetime.
For consultation, please contact us:
Our team will be pleased to assist you.